CVE-2026-50034 PUBLISHED

Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Cleartext Transmission of Sensitive Information

Assigner: icscert
Reserved: 10.06.2026 Published: 18.06.2026 Updated: 18.06.2026

An attacker within BLE communication range can passively intercept wireless traffic and obtain sensitive health-related information, including glucose measurement values.

CVSS Vector: CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
CVSS Score: 6.5

Attack Vector	Adjacent Network	Scope	Unchanged
Attack Complexity	Low	Confidentiality Impact	High
Privileges Required	None	Integrity Impact	None
User Interaction	None	Availability Impact	None

CVSS 3.1

CVSS Vector: CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N
CVSS Score: 7.1

Exploitability Metrics		Vulnerable System Impact Metrics		Subsequent System Impact Metrics
Attack Vector	Adjacent	Confidentiality	High	Confidentiality	None
Attack Complexity	Low	Integrity	None	Integrity	None
Attack Requirements	None	Availability	None	Availability	None
Privileges Required	None
User Interaction	None

CVSS 4.0

Product Status

Vendor	Apollo Pharmacy
Product	Blood Glucose Monitoring System (Model No. APG-01 BT)
Versions	Default: unaffected Version 0x0110_v1.1.0 is affected

Workarounds

Apollo Pharmacy did not respond to CISA's requests to coordinate. Users are encouraged to reach out to Apollo Pharmacy directly for more information: https://www.apollopharmacy.in/contact-us

CISA recommends users follow the guidance in the Understanding Bluetooth Technology blog: https://www.cisa.gov/news-events/news/understanding-bluetooth-technology

Credits

Rishitha Pucchakayala and Centre for Development of Advanced Computing (Hyderabad) reported these vulnerabilities to CISA. finder

References

Problem Types

CWE-319 CWE